Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin?

Lancet

Volumn 348, Issue 9020, 1996, Pages 106-109

  Brennan, Paul ^a   Ollier, Bill ^a   Worthington, Jane ^a   Hajeer, Ali ^a   Silman, Alan ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR4 ANTIGEN; PROLACTIN;

BREAST FEEDING; CHROMOSOME 6; DNA POLYMORPHISM; FERTILITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK; SHORT SURVEY;

EID: 0030582186     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)02037-5     Document Type: Note

References (40)

1. 1 Symmons DPM, Barrett EM, Bankhead CR, Scott DGI, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994; 33: 735-39.
2. 2 Holmdahl R, Carlsten H, Jannsson L, et al. Oestrogen is a potent immunomodulator of murine experimental rheumatoid disease. Br J Rheumatol 1989; 28: 54-58.
3. 3 Nelson JL, Steinberg AD. Sex steroids, autoimmunity and autoimmune disease. In: Berczi I, Kovaks K, eds. Hormones and immunity. Lancaster: MTP Press, 1987: 93-119.
4. 4 Hazes JMW, Van Zeben D. Oral contraception and its possible protection against rheumatoid arthritis. Ann Rheum Dis 1991; 50: 72-74.
5. 5 Masi AT, Feigenbaum SL, Chatterton RT. Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunological and microvascular systems. Semin Arthritis Rheum 1995; 25: 1-27.
6. 6 Da Silva JAP, Spector TD. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 1992; 11: 189-94.
7. 7 Silman AJ, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992; 35: 152-55.
8. 8 Del Junco DJ, Annegers JF, Coulam CB, Luthra HS. The relationship between rheumatoid arthritis and reproductive function. Br J Rheumatol 1989; 28 (suppl 1): 33 (abstr).
9. 9 Nelson JL, Koepsell TD, Dugowson CE, Voigt LF, Daling JR, Hansen JA. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum 1993; 36: 7-14.
10. 10 Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994; 37: 808-13.
11. 11 Jorgensen C, Picot MC, Bologna C, Sany J. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 1996; 56: 94-98.
12. 12 Brennan P, Silman AJ. An investigation of gene-environment in the etiology of rheumatoid arthritis. Am J Epidemiol 1994; 140: 453-60.
13. 13 Noel GL, Suh HK, Frantz AG. Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects. J Clin Endocrinol Metab 1974; 38: 413-23.
14. 14 Davies JRE. Prolactin and related peptides in pregnancy. Clin Endocrinol Metab 1990; 4: 273-90.
15. 15 Brennan P, Silman A. Why the gender difference in susceptibility to rheumatoid arthritis? Ann Rheum Dis 1995; 54: 694-95.
16. 16 Jara LJ, Lavalle C, Fraga A, et al. Prolactin, immunoregulation and autoimmune diseases. Semin Arthritis Rheum 1991; 20: 273-84.
17. 17 Chikanza IC, Pownall R, Panayi GS. Immunoendocrine interactions in the pathogenesis of rheumatid arthritis: initiating and perpetuating factors? Br J Rheumatol 1990; 29 (suppl 2): 22 (abstr).
18. 18 Gagnerault MC, Touraine P, Savino W, Kelly PA, Dardenne M. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 1993; 150: 5673-81.
19. 19 Buskila D, Sukenik S, Shoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991; 26: 118-23.
20. 20 Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137-41.
21. 21 McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994; 21: 843-50.
22. 22 Weber G, Frey H. Treatment of psoriatic arthritis with bromocriptine. J Am Acad Dermatol 1987; 16: 388-89.
23. 23 Nagy E, Chalmers IM, Fletcher DB, Friesen HG, Berczi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991; 18: 1662-68.
24. 24 McMurray RW, Allen SH, Pepmueller PH, Keisler D, Cassidy JT. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity. J Rheumatol 1995; 22: 1577-80.
25. 25 Mateo L, Nolla JM, Bonnin MR, Navarro MA, Juanola X, Roig-Escofet D. Prolactin, androgens and bone mineral density in men with rheumatoid arthritis. Arthritis Rheum 1994; 37: S223 (abstr).
26. 26 Matt KS, Castro L, Yocum DE, Zautra A, Roth S. The effect of stress and flare on neuroendocrine and immune function in rheumatoid arthritis patients. Arthritis Rheum 1994; 37 (suppl): S246 (abstr).
27. 27 Chikanza IC, Panayi GS. Prolactin secretion in rheumatoid arthritis. Br J Rheumatol 1988; 27: 324.
28. 28 Chikanza IC, Petrou P, Chrousos G, Kingsley G, Panayi GS. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunogenetics and therapeutic implications. Br J Rheumatol 1993; 32: 445-48.
29. 29 Ollier W, Thomson W. Populatin genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992; 18: 741-59.
30. 30 Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13.
31. 31 Hajeer AH, Worthington J, Silman AJ, Ollier WER. TNF micro satellite polymorphisms in rheumatoid arthritis. Arthritis Rheum 1995; 38: S374 (abstr).
32. 32 Maeda H, Juji T, Sonozaki H, Okitsu K. HLA DR4 and rheumatoid arthritis in Japanese people. Ann Rheum Dis 1981; 40: 299-302.
33. 33 Dizier MH, Eliaou JF, Babron MC, et al. Investigation of the HLA component in rheumatoid arthritis by using the marker association-segregation method: rejection of the unifying shared epitope hypothesis. Am J Hum Genet 1993; 53: 715-21.
34. 34 Thomson W, Ollier W. Non-radioactive aso typing for class II - the way forward. Eur J Immunol 1992; 19: 169-75.
35. 35 Jawaheer D, Ollier WER, Thomson W. Multiplex ARMS-RFLP: a simple and rapid method for HLA DR4 subtyping. Eur J Immunogenet 1993; 20: 175-87.
36. 36 MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA DRB1 *0401/0404 genotype and rheumatoid arthritis: increased association in males, young age at onset and disease severity. J Rheum 1995; 22: 1032-36.
37. 37 Nelson JL, Dugowson C, Richards M, Koepsell T, Gooley T, Hansen JA. Risk of rheumatoid arthritis, parity, and the DRB1 "shared epitope" sequence. Arthritis Rheum 1995; 38 (suppl): S232 (abstr).
38. 38 Evans AM, Petersen JW, Sekhon GS, DeMars R. Use of human lymphoblastoid deletion mutations to map the prolactin gene on human chromosome 6p. Am J Hum Genet 1988; 43: A143 (abstr).
39. 39 Myal Y, DiMattia GE, Gregory CA, Friesen HG, Hamerton JL, Shiu RPC. A BgIII RFLP at the human prolactin gene locus on chromosome 6. Nucl Acids Res 1991; 19: 1167.
40. 40 Farid NR, Noel EP, Sampson L, Russell NA. Prolactin secreting adenomata are possibly associated with HLA-B8. Tissue Antigens 1980; 15: 333-35.